Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in FTRE — Fortrea Holdings Inc.

CIK 72971 SAN FRANCISCO, CA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,846,939
+$1,254,536 QoQ
Shares Held
106,146
+68.8% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. FTRE ranks #108 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,846,939 106,146
2026-03-31 $592,403 62,888
2025-12-31 $2,069,946 119,997
2025-09-30 $744,823 88,459
2025-06-30 $369,425 74,783
2025-03-31 $234,704 31,087
2024-12-31 $628,262 33,687
2024-09-30 $947,340 47,367
2024-06-30 $3,718,504 159,319
2024-03-31 $7,825,933 194,966
2023-12-31 $6,460,233 185,107
2023-09-30 $4,611,765 161,307